1. Home
  2. GSRT vs LSBPW Comparison

GSRT vs LSBPW Comparison

Compare GSRT & LSBPW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GSRT
  • LSBPW
  • Stock Information
  • Founded
  • GSRT 2023
  • LSBPW N/A
  • Country
  • GSRT United States
  • LSBPW China
  • Employees
  • GSRT N/A
  • LSBPW 758
  • Industry
  • GSRT
  • LSBPW Biotechnology: Pharmaceutical Preparations
  • Sector
  • GSRT
  • LSBPW Health Care
  • Exchange
  • GSRT Nasdaq
  • LSBPW Nasdaq
  • Market Cap
  • GSRT N/A
  • LSBPW N/A
  • IPO Year
  • GSRT 2024
  • LSBPW N/A
  • Fundamental
  • Price
  • GSRT N/A
  • LSBPW $0.05
  • Analyst Decision
  • GSRT
  • LSBPW
  • Analyst Count
  • GSRT 0
  • LSBPW 0
  • Target Price
  • GSRT N/A
  • LSBPW N/A
  • AVG Volume (30 Days)
  • GSRT 63.1K
  • LSBPW N/A
  • Earning Date
  • GSRT 01-01-0001
  • LSBPW N/A
  • Dividend Yield
  • GSRT N/A
  • LSBPW N/A
  • EPS Growth
  • GSRT N/A
  • LSBPW N/A
  • EPS
  • GSRT N/A
  • LSBPW N/A
  • Revenue
  • GSRT N/A
  • LSBPW N/A
  • Revenue This Year
  • GSRT N/A
  • LSBPW N/A
  • Revenue Next Year
  • GSRT N/A
  • LSBPW N/A
  • P/E Ratio
  • GSRT N/A
  • LSBPW N/A
  • Revenue Growth
  • GSRT N/A
  • LSBPW N/A
  • 52 Week Low
  • GSRT $9.97
  • LSBPW N/A
  • 52 Week High
  • GSRT $10.04
  • LSBPW N/A
  • Technical
  • Relative Strength Index (RSI)
  • GSRT N/A
  • LSBPW N/A
  • Support Level
  • GSRT N/A
  • LSBPW N/A
  • Resistance Level
  • GSRT N/A
  • LSBPW N/A
  • Average True Range (ATR)
  • GSRT 0.00
  • LSBPW 0.00
  • MACD
  • GSRT 0.00
  • LSBPW 0.00
  • Stochastic Oscillator
  • GSRT 0.00
  • LSBPW 0.00

About LSBPW LakeShore Biopharma Co. Ltd

LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.

Share on Social Networks: